-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Sana Biotechnology, Raises Price Target to $7

Benzinga·04/14/2026 13:52:44
Listen to the news
Wedbush analyst Martin Fan maintains Sana Biotechnology (NASDAQ:SANA) with a Outperform and raises the price target from $6 to $7.